These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6607977)

  • 1. Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate.
    Jaffe N; Prudich J; Knapp J; Wang YM; Bowman R; Cangir A; Ayala A; Chuang V; Wallace S
    J Clin Oncol; 1983 Jul; 1(7):428-31. PubMed ID: 6607977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma.
    Jaffe N; Robertson R; Ayala A; Wallace S; Chuang V; Anzai T; Cangir A; Wang YM; Chen T
    J Clin Oncol; 1985 Aug; 3(8):1101-4. PubMed ID: 3874932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of primary osteosarcoma with chemotherapy.
    Jaffe N; Robertson R; Takaue Y; Cangir A; Wallace S; Carrasco H; Eftekhari F; Ayala A; Wang A
    Cancer; 1985 Aug; 56(3):461-6. PubMed ID: 3873985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental studies on high-dose methotrexate with citrovorum factor chemotherapy for 89Sr-induced osteosarcoma murine model.
    Tomita K
    Jpn J Antibiot; 1986 May; 39(5):1219-27. PubMed ID: 3489843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the effect of high-dose methotrexate-citrovorum factor treatment for 89Sr induced osteosarcoma in mice (author's transl)].
    Nakamura T
    Nihon Seikeigeka Gakkai Zasshi; 1982 Feb; 56(2):149-61. PubMed ID: 6978919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
    Perez C; Wang YM; Sutow WW; Herson J
    Cancer Clin Trials; 1978; 1(2):107-11. PubMed ID: 316368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of delayed leucovorin "rescue" following high-dose methotrexate in children.
    Camitta BM; Holcenberg JS
    Med Pediatr Oncol; 1978; 5(1):55-9. PubMed ID: 370536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
    Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
    Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methotrexate with a safe rescue program.
    Decker DA; Edmonson JH; Gilchrist GS; Kovach JS; Offord JR; Taylor WF
    Oncology; 1981; 38(5):262-4. PubMed ID: 6973732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.
    Erttmann R; Bielack S; Landbeck G
    Cancer Chemother Pharmacol; 1985; 15(2):101-4. PubMed ID: 3874719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced citrovorum factor rescue for high-dose methotrexate therapy in childhood malignancies.
    Sasaki K; Tanaka J; Murakami T; Matuoka H; Fujimoto T; Taguchi H
    Cancer Drug Deliv; 1985; 2(1):77-86. PubMed ID: 3876873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.
    Jaffe N; Gorlick R
    J Clin Oncol; 2008 Sep; 26(27):4365-6. PubMed ID: 18802144
    [No Abstract]   [Full Text] [Related]  

  • 15. Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
    Jürgens H; Ebell W; Bachmann R; Kupke I; Richter O; Andräs A; Göbel U
    Pediatr Pharmacol (New York); 1983; 3(3-4):157-65. PubMed ID: 6610851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
    Saeter G; Alvegård TA; Elomaa I; Stenwig AE; Holmström T; Solheim OP
    J Clin Oncol; 1991 Oct; 9(10):1766-75. PubMed ID: 1717666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of high-dose methotrexate after intravenous administration in Chinese osteosarcoma patients from a single institution.
    Zhang W; Zhang Q; Tian X; Zhao H; Lu W; Zhen J; Niu X
    Chin Med J (Engl); 2015 Jan; 128(1):111-8. PubMed ID: 25563323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of liver and renal functions on the changes in serum methotrexate (MTX) level in high-dose MTX therapy].
    Sato T; Nakanishi K; Takahashi M; Sato K; Miura T; Kuzuya T; Mizuno M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2375-9. PubMed ID: 2260874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
    Leber H; Kotz R; Chiari K; Endler T; Gabl F; Krisch K; Salzer-Kuntschik M
    Wien Klin Wochenschr; 1981 Apr; 93(7):236-40. PubMed ID: 7020262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra-arterial infusion of high dose methotrexate therapy in recurrent gliomas].
    Hayashi A; Kyuma Y
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1461-6. PubMed ID: 2117886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.